2
项与 CD123 CAR-T Cell(UTC Therapeutics) 相关的临床试验Safety and Efficacy Study of Chimeric Antigen Receptor T (CAR-T) Cells in the Treatment of Relapsed/Refractory Hematological Malignancies
The primary purpose of this study is to determine the safety and efficacy of novel autologous CAR-T cells in patients with relapsed/refractory hematological malignancies.
Safety and Efficacy Study of Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies
The primary purpose of this study is to determine the safety and efficacy of novel autologous CAR-T cells in patients with hematopoietic and lymphoid malignancies.
100 项与 CD123 CAR-T Cell(UTC Therapeutics) 相关的临床结果
100 项与 CD123 CAR-T Cell(UTC Therapeutics) 相关的转化医学
100 项与 CD123 CAR-T Cell(UTC Therapeutics) 相关的专利(医药)
100 项与 CD123 CAR-T Cell(UTC Therapeutics) 相关的药物交易